Bioconductor: An Open-Source Platform for Genomics that Supports Reproducible Science
Official title: Bioconductor: An Open-Source, Open-Development Computing Resource for Genomics
Funded at Dana-Farber Cancer Inst · NIH-11421613 · Data updated 2026-11-12
A long-running, freely available computing resource helps researchers analyze genomic data more reliably and reproducibly with open tools and workflows.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dana-Farber Cancer Inst NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | September 28, 2006 |
| Project end | July 31, 2031 |
| Funding year | 2026 |
| Award (this year) | $922,832 |
| NIH project number | 2U24HG004059-22 |
| Project ID | NIH-11421613 on NIH RePORTER |
Who could benefit from this research
✓Could help
Researchers and clinicians who rely on genomic data analysis to study diseases could benefit from continued access to Bioconductor tools and training.
✕Less likely to help
There is no direct patient participation; benefits are to the research community and downstream patient-focused studies.
What this research studies
Bioconductor provides open-source software and infrastructure for genomic data science used widely in research and teaching. It promotes reproducible analyses, interoperable data structures, and a shared ecosystem of tools that many labs rely on for large-scale studies. The project also offers training through workshops and open materials, supporting a broad community of researchers. This renewal seeks continued NIH support to maintain and grow the platform for future genomic discoveries.
Why it matters
Potential benefit: If supported, Bioconductor will continue to enable researchers to perform robust genomic analyses more efficiently, accelerating discoveries that could benefit patients.
How similar studies have gone: Bioconductor has a long track record with widespread adoption and impact in thousands of publications and software downloads, demonstrating success of open, community-driven software in genomics.
Where this research is happening
-
Dana-Farber Cancer Inst
Boston, United States Active
Researchers
- Principal investigator: Irizarry, Rafael Angel — Dana-Farber Cancer Inst
- Study coordinator: Irizarry, Rafael Angel
Related research
Other NIH-funded projects on the same topics.
-
Helping young people with cancer understand their genetic risks
This study is creating a special program to help teenagers and young adults with hereditary cancer risks learn about their health and make smart choices, while also supporting their families along the way.
-
Core administrative hub for a multifaceted cancer center program
A large, international cancer research program at Dana-Farber aims to advance a curative strategy for multiple myeloma by coordinating translational research, clinical trials, and data analysis.
-
Automated, interactive lab tool to define radiation targets in cancer care
Aims to make it easier and safer to outline the area to treat in radiation therapy for cancers by using smart software and a patient-friendly interface.
-
Cancer Atlas Network data hub to share big cancer data
A national project helps researchers store, harmonize, and share large cancer data collections so doctors and scientists can learn from many patients.
-
Bridge-building cancer research partnership for education, outreach, and science
A joint effort between UMass Boston and Harvard Cancer Consortium to accelerate cancer research and education by connecting lower-resourced institutions with a leading cancer center.
-
NexTGen: Next-Generation T cell therapy for childhood cancers
A charity-friendly overview: researchers at Dana-Farber are developing advanced engineered T-cell therapies to treat pediatric solid cancers like brain tumors and sarcomas.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.